Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party

This publication has 19 references indexed in Scilit:

• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis
  Cancer, 1995
• Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
  Journal of Clinical Oncology, 1995
• Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer
  European Journal Of Cancer, 1994
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
  Journal of Clinical Oncology, 1993
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer
  Published by S. Karger AG ,1987
• A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.
  Journal of Clinical Oncology, 1986
• Historical notes on lung cancer before and after Graham's successful pneumonectomy in 1933
  The American Journal of Surgery, 1982